Clinical Trial of Natural Therapeutics for COVID-19 and Other Acute Respiratory Viral Infections

Exclusion Criteria

• •Severe acute respiratory illness (SARI)-defined as An acute respiratory illness with a history of fever or measured fever of ≥ 38 °C and cough and/or throat with onset within the past 10 days, requiring hospitalization or with SPO2≤92%
• •History of hypersensitivity to the investigational product or components therein
• •Conditions that may be regarded as contraindications to the investigational medicinal product include known allergic reactions and rashes to any herbal medicines and any untoward reactions to any herbal medications such as bleeding, headaches, high blood pressure, heart failure, seizures, agitation, etc.
• •Severe organ impairment (liver, kidney, brain, heart)
• •Inability to return for post-discharge follow-up
• •Females who are pregnant or intend to become pregnant or are breastfeeding during the trial